Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pituitary ACTH Hypersecretion | 18 | 2024 | 180 | 3.420 |
Why?
|
Pituitary Neoplasms | 37 | 2024 | 1322 | 3.050 |
Why?
|
Acromegaly | 18 | 2022 | 317 | 1.670 |
Why?
|
Adenoma | 26 | 2022 | 2159 | 1.590 |
Why?
|
Cushing Syndrome | 8 | 2021 | 241 | 0.860 |
Why?
|
Petrosal Sinus Sampling | 3 | 2021 | 22 | 0.840 |
Why?
|
Central Nervous System Cysts | 2 | 2020 | 56 | 0.780 |
Why?
|
Adrenocorticotropic Hormone | 11 | 2022 | 619 | 0.730 |
Why?
|
Pituitary Gland | 8 | 2021 | 635 | 0.650 |
Why?
|
Radiosurgery | 5 | 2020 | 1330 | 0.650 |
Why?
|
Sella Turcica | 3 | 2010 | 117 | 0.540 |
Why?
|
Monitoring, Intraoperative | 2 | 2019 | 948 | 0.520 |
Why?
|
Pituitary Diseases | 3 | 2016 | 137 | 0.510 |
Why?
|
Neurosurgical Procedures | 5 | 2020 | 2076 | 0.500 |
Why?
|
Pituitary Apoplexy | 1 | 2014 | 29 | 0.460 |
Why?
|
Salvage Therapy | 1 | 2020 | 1273 | 0.440 |
Why?
|
Antidotes | 1 | 2014 | 138 | 0.440 |
Why?
|
Somatostatin | 7 | 2020 | 458 | 0.430 |
Why?
|
Prolactinoma | 6 | 2022 | 114 | 0.390 |
Why?
|
Blood Coagulation Factors | 1 | 2014 | 371 | 0.390 |
Why?
|
Sphenoid Bone | 3 | 2014 | 176 | 0.380 |
Why?
|
Hydrocortisone | 11 | 2024 | 1840 | 0.380 |
Why?
|
Human Growth Hormone | 7 | 2020 | 651 | 0.370 |
Why?
|
Hypopituitarism | 4 | 2023 | 253 | 0.330 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 810 | 0.310 |
Why?
|
Nose | 1 | 2012 | 522 | 0.310 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9412 | 0.270 |
Why?
|
Dopamine Agonists | 3 | 2020 | 347 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 15 | 2021 | 36742 | 0.250 |
Why?
|
Warfarin | 1 | 2014 | 1493 | 0.250 |
Why?
|
Insulin-Like Growth Factor I | 10 | 2020 | 1942 | 0.240 |
Why?
|
Receptors, Somatotropin | 3 | 2020 | 58 | 0.230 |
Why?
|
Hypophysectomy | 2 | 2021 | 114 | 0.230 |
Why?
|
Adrenal Insufficiency | 3 | 2024 | 195 | 0.230 |
Why?
|
Corticotropin-Releasing Hormone | 3 | 2012 | 362 | 0.210 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 4 | 2020 | 49 | 0.210 |
Why?
|
Hyperprolactinemia | 2 | 2022 | 124 | 0.210 |
Why?
|
Brain Injuries | 1 | 2014 | 2057 | 0.200 |
Why?
|
Saliva | 2 | 2018 | 853 | 0.200 |
Why?
|
Brain Neoplasms | 4 | 2020 | 9116 | 0.190 |
Why?
|
Receptors, Somatostatin | 2 | 2020 | 138 | 0.180 |
Why?
|
Body Composition | 5 | 2017 | 2462 | 0.180 |
Why?
|
Retrospective Studies | 26 | 2024 | 81746 | 0.170 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2020 | 43 | 0.170 |
Why?
|
Middle Aged | 52 | 2023 | 223422 | 0.170 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 602 | 0.160 |
Why?
|
Frozen Sections | 1 | 2019 | 153 | 0.160 |
Why?
|
Treatment Outcome | 14 | 2023 | 65364 | 0.160 |
Why?
|
Adult | 54 | 2022 | 223583 | 0.150 |
Why?
|
Ependymoma | 3 | 2010 | 328 | 0.150 |
Why?
|
Reoperation | 3 | 2022 | 4329 | 0.150 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2020 | 164 | 0.150 |
Why?
|
Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.150 |
Why?
|
Peptides, Cyclic | 2 | 2017 | 391 | 0.140 |
Why?
|
Humans | 79 | 2024 | 767991 | 0.140 |
Why?
|
Albuterol | 1 | 1998 | 211 | 0.140 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1280 | 0.140 |
Why?
|
Intraoperative Period | 2 | 2019 | 512 | 0.130 |
Why?
|
Male | 53 | 2021 | 364641 | 0.130 |
Why?
|
Female | 58 | 2021 | 397113 | 0.130 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2016 | 241 | 0.130 |
Why?
|
Aged | 34 | 2020 | 171446 | 0.130 |
Why?
|
Cytodiagnosis | 1 | 2019 | 450 | 0.130 |
Why?
|
Combined Modality Therapy | 6 | 2020 | 8535 | 0.120 |
Why?
|
Radiotherapy | 2 | 2020 | 1501 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1183 | 0.120 |
Why?
|
Karnofsky Performance Status | 1 | 2014 | 162 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1014 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3210 | 0.110 |
Why?
|
Craniotomy | 2 | 1996 | 736 | 0.110 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1999 | 735 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 1998 | 572 | 0.110 |
Why?
|
Salivary Glands | 1 | 1995 | 231 | 0.110 |
Why?
|
Thyrotropin | 2 | 2014 | 835 | 0.110 |
Why?
|
Craniopharyngioma | 2 | 2010 | 279 | 0.110 |
Why?
|
Choristoma | 1 | 1995 | 205 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1656 | 0.100 |
Why?
|
Growth Hormone | 6 | 2022 | 573 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 1995 | 263 | 0.100 |
Why?
|
Adolescent | 21 | 2021 | 89155 | 0.100 |
Why?
|
International Normalized Ratio | 1 | 2014 | 382 | 0.100 |
Why?
|
Hormone Replacement Therapy | 2 | 2010 | 757 | 0.100 |
Why?
|
Glasgow Coma Scale | 1 | 2014 | 574 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2256 | 0.100 |
Why?
|
Chordoma | 1 | 1995 | 349 | 0.090 |
Why?
|
Patient Care Team | 2 | 2020 | 2521 | 0.090 |
Why?
|
Cysts | 1 | 2016 | 685 | 0.090 |
Why?
|
Plasma | 1 | 2014 | 584 | 0.090 |
Why?
|
Aged, 80 and over | 12 | 2020 | 59598 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7445 | 0.090 |
Why?
|
Brain Stem | 2 | 1995 | 859 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2011 | 326 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2014 | 561 | 0.080 |
Why?
|
Pituitary Gland, Posterior | 1 | 2008 | 42 | 0.080 |
Why?
|
Adrenalectomy | 1 | 2011 | 348 | 0.080 |
Why?
|
Proteins | 3 | 2011 | 6009 | 0.080 |
Why?
|
Recurrence | 4 | 2015 | 8507 | 0.080 |
Why?
|
Nelson Syndrome | 1 | 2007 | 20 | 0.070 |
Why?
|
DNA, Intergenic | 1 | 2008 | 108 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4525 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3553 | 0.070 |
Why?
|
Ki-67 Antigen | 2 | 2008 | 630 | 0.070 |
Why?
|
Gene Silencing | 2 | 2011 | 1505 | 0.070 |
Why?
|
Inhibins | 2 | 2000 | 210 | 0.070 |
Why?
|
Young Adult | 9 | 2020 | 60048 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2863 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1024 | 0.070 |
Why?
|
Microsurgery | 1 | 2012 | 800 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2015 | 14718 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2012 | 1474 | 0.060 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2006 | 64 | 0.060 |
Why?
|
Remission Induction | 3 | 2021 | 2409 | 0.060 |
Why?
|
Morbidity | 2 | 2003 | 1754 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3329 | 0.060 |
Why?
|
Tumor Burden | 2 | 2022 | 1904 | 0.060 |
Why?
|
Differential Threshold | 1 | 2004 | 80 | 0.060 |
Why?
|
Meningioma | 2 | 2010 | 1220 | 0.060 |
Why?
|
ROC Curve | 2 | 2020 | 3628 | 0.060 |
Why?
|
Growth Disorders | 1 | 2009 | 635 | 0.060 |
Why?
|
Child | 10 | 2014 | 80906 | 0.060 |
Why?
|
Quality of Life | 5 | 2023 | 13489 | 0.050 |
Why?
|
Dexamethasone | 2 | 2009 | 1964 | 0.050 |
Why?
|
Postoperative Complications | 7 | 2018 | 15831 | 0.050 |
Why?
|
False Negative Reactions | 1 | 2004 | 571 | 0.050 |
Why?
|
Gene Expression | 3 | 2002 | 7597 | 0.050 |
Why?
|
Intracranial Aneurysm | 2 | 1996 | 1271 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2011 | 7876 | 0.050 |
Why?
|
Postoperative Period | 2 | 2020 | 1826 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13665 | 0.050 |
Why?
|
Octreotide | 2 | 2017 | 156 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3467 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2629 | 0.050 |
Why?
|
Prolactin | 2 | 2022 | 627 | 0.050 |
Why?
|
Endoscopy | 1 | 2012 | 1854 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 13000 | 0.050 |
Why?
|
Receptors, Growth Factor | 2 | 2000 | 324 | 0.050 |
Why?
|
Carotid Artery Diseases | 1 | 1987 | 879 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6517 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15442 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39345 | 0.040 |
Why?
|
Time | 1 | 2021 | 552 | 0.040 |
Why?
|
Asthma | 1 | 1998 | 6273 | 0.040 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1999 | 29 | 0.040 |
Why?
|
Receptors, Neuropeptide | 1 | 1999 | 106 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2022 | 26375 | 0.040 |
Why?
|
Hypothalamic Hormones | 1 | 1999 | 145 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5536 | 0.040 |
Why?
|
Matched-Pair Analysis | 1 | 1999 | 285 | 0.040 |
Why?
|
Health Care Costs | 1 | 2012 | 3239 | 0.040 |
Why?
|
Postoperative Care | 1 | 2005 | 1480 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2006 | 12797 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4854 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 8082 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2019 | 22287 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 13053 | 0.040 |
Why?
|
Ergolines | 1 | 2017 | 56 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 759 | 0.040 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 1999 | 304 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2953 | 0.040 |
Why?
|
Hospital Costs | 1 | 2003 | 957 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10396 | 0.030 |
Why?
|
Time Factors | 5 | 2020 | 40214 | 0.030 |
Why?
|
Lipodystrophy | 1 | 2017 | 145 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11068 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1557 | 0.030 |
Why?
|
Cranial Fossa, Posterior | 1 | 1996 | 134 | 0.030 |
Why?
|
Basilar Artery | 1 | 1996 | 207 | 0.030 |
Why?
|
Vertebral Artery | 1 | 1996 | 185 | 0.030 |
Why?
|
Adrenal Gland Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
Galactorrhea | 1 | 1995 | 23 | 0.030 |
Why?
|
Circadian Rhythm | 2 | 2018 | 2591 | 0.030 |
Why?
|
Calcium-Binding Proteins | 2 | 2011 | 1083 | 0.030 |
Why?
|
Testosterone | 1 | 2006 | 2491 | 0.030 |
Why?
|
Survival Rate | 2 | 1999 | 12828 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12536 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1181 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29979 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13658 | 0.030 |
Why?
|
Neuropeptides | 1 | 1999 | 951 | 0.030 |
Why?
|
DNA Methylation | 1 | 2008 | 4426 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 1998 | 1695 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2017 | 707 | 0.030 |
Why?
|
Prospective Studies | 2 | 2017 | 54924 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1998 | 1104 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 2016 | 552 | 0.030 |
Why?
|
Subcutaneous Fat | 1 | 2016 | 404 | 0.030 |
Why?
|
Skull Base | 1 | 1996 | 294 | 0.030 |
Why?
|
Prednisone | 1 | 2017 | 1567 | 0.030 |
Why?
|
Statistics as Topic | 1 | 1999 | 2357 | 0.030 |
Why?
|
Hospitals, General | 1 | 1997 | 806 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 968 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 1995 | 393 | 0.020 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1991 | 95 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1932 | 0.020 |
Why?
|
Skull Neoplasms | 1 | 1992 | 173 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 2889 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 625 | 0.020 |
Why?
|
Cerebellum | 2 | 1996 | 1522 | 0.020 |
Why?
|
Radiotherapy, Conformal | 1 | 2014 | 549 | 0.020 |
Why?
|
Endocrinology | 1 | 1997 | 443 | 0.020 |
Why?
|
Rhinoplasty | 1 | 1995 | 241 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 1991 | 52 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 1997 | 939 | 0.020 |
Why?
|
Gonadotropins | 1 | 1991 | 241 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2006 | 10470 | 0.020 |
Why?
|
Blood Glucose | 2 | 2017 | 6429 | 0.020 |
Why?
|
Spinal Nerves | 1 | 1990 | 92 | 0.020 |
Why?
|
Aftercare | 1 | 2016 | 916 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1998 | 2253 | 0.020 |
Why?
|
Hospitals | 1 | 2003 | 3886 | 0.020 |
Why?
|
Chondrosarcoma | 1 | 1992 | 305 | 0.020 |
Why?
|
Sarcoma | 2 | 2008 | 1804 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2003 | 5349 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1536 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2006 | 12464 | 0.020 |
Why?
|
Neurosurgery | 1 | 1996 | 682 | 0.020 |
Why?
|
Neurology | 1 | 1997 | 786 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 1990 | 160 | 0.020 |
Why?
|
Trigeminal Nerve | 1 | 1990 | 248 | 0.020 |
Why?
|
Disabled Persons | 1 | 1998 | 1210 | 0.020 |
Why?
|
Tumor Cells, Cultured | 3 | 2006 | 6119 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20218 | 0.020 |
Why?
|
Fathers | 1 | 2011 | 377 | 0.020 |
Why?
|
Encephalocele | 1 | 1989 | 135 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2009 | 14783 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 4576 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2008 | 171 | 0.020 |
Why?
|
Bromocriptine | 1 | 2007 | 93 | 0.020 |
Why?
|
Occipital Lobe | 1 | 1989 | 376 | 0.020 |
Why?
|
Lipoproteins | 1 | 2012 | 879 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 2916 | 0.020 |
Why?
|
Glycoproteins | 1 | 1995 | 2201 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 687 | 0.020 |
Why?
|
Ligation | 1 | 1987 | 446 | 0.020 |
Why?
|
Physicians, Family | 1 | 2008 | 349 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1698 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13289 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2008 | 20757 | 0.020 |
Why?
|
Drug Interactions | 1 | 2009 | 1419 | 0.010 |
Why?
|
Carotid Artery, Internal | 1 | 1987 | 440 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2003 | 26420 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2008 | 2299 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1990 | 715 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8637 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1892 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3986 | 0.010 |
Why?
|
Cell Division | 2 | 2002 | 4473 | 0.010 |
Why?
|
Chronic Disease | 1 | 1998 | 9384 | 0.010 |
Why?
|
Family Characteristics | 1 | 2008 | 1003 | 0.010 |
Why?
|
Infant | 2 | 2003 | 36534 | 0.010 |
Why?
|
Transfection | 2 | 2002 | 5757 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1990 | 1266 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1114 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16723 | 0.010 |
Why?
|
Hormones | 1 | 2006 | 866 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1995 | 4937 | 0.010 |
Why?
|
Olivary Nucleus | 1 | 1982 | 131 | 0.010 |
Why?
|
Cerebellar Cortex | 1 | 1982 | 108 | 0.010 |
Why?
|
Lipids | 1 | 2012 | 3342 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41749 | 0.010 |
Why?
|
Mothers | 1 | 2011 | 2209 | 0.010 |
Why?
|
Child, Preschool | 1 | 2003 | 42665 | 0.010 |
Why?
|
Activin Receptors | 1 | 2000 | 40 | 0.010 |
Why?
|
Prolactin-Releasing Hormone | 1 | 1999 | 3 | 0.010 |
Why?
|
Thymidine | 1 | 2000 | 297 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2131 | 0.010 |
Why?
|
Arousal | 1 | 2006 | 1179 | 0.010 |
Why?
|
Hypogonadism | 1 | 2006 | 805 | 0.010 |
Why?
|
Reference Values | 2 | 1998 | 4938 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1999 | 325 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 378 | 0.010 |
Why?
|
17-Hydroxycorticosteroids | 1 | 1998 | 38 | 0.010 |
Why?
|
Activin Receptors, Type I | 1 | 1999 | 133 | 0.010 |
Why?
|
Activin Receptors, Type II | 1 | 1999 | 122 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 30211 | 0.010 |
Why?
|
Activins | 1 | 2000 | 211 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74936 | 0.010 |
Why?
|
Affect | 1 | 2006 | 1495 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1998 | 222 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3858 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6843 | 0.010 |
Why?
|
Cyclins | 1 | 2000 | 605 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1998 | 6071 | 0.010 |
Why?
|
Emotions | 1 | 2009 | 2766 | 0.010 |
Why?
|
Radiography | 1 | 1987 | 6983 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2006 | 2197 | 0.010 |
Why?
|
MicroRNAs | 1 | 2011 | 3804 | 0.010 |
Why?
|
United States | 1 | 2003 | 73027 | 0.010 |
Why?
|
Endocrine System Diseases | 1 | 1997 | 250 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 17128 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1998 | 792 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12075 | 0.010 |
Why?
|
Follistatin | 1 | 1995 | 138 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 1995 | 208 | 0.010 |
Why?
|
Paranasal Sinuses | 1 | 1996 | 267 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4168 | 0.010 |
Why?
|
Bone Density | 1 | 2006 | 3573 | 0.010 |
Why?
|
Blotting, Western | 1 | 2000 | 5024 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1998 | 1752 | 0.010 |
Why?
|
Arteries | 1 | 1996 | 1127 | 0.010 |
Why?
|
Estradiol | 1 | 1998 | 1951 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1996 | 1264 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1999 | 4114 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 1990 | 111 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10590 | 0.010 |
Why?
|
Mental Disorders | 1 | 2009 | 6875 | 0.000 |
Why?
|
Research | 1 | 1997 | 1979 | 0.000 |
Why?
|
Cognition | 1 | 2006 | 7072 | 0.000 |
Why?
|
Cytoplasmic Granules | 1 | 1990 | 574 | 0.000 |
Why?
|
Base Sequence | 1 | 1999 | 12418 | 0.000 |
Why?
|
Meningomyelocele | 1 | 1989 | 182 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13420 | 0.000 |
Why?
|
Cerebellar Diseases | 1 | 1989 | 227 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1990 | 2559 | 0.000 |
Why?
|
Cerebral Ventricles | 1 | 1989 | 550 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1997 | 1661 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15660 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17617 | 0.000 |
Why?
|
Cytoplasm | 1 | 1990 | 1505 | 0.000 |
Why?
|
Microtubules | 1 | 1990 | 1064 | 0.000 |
Why?
|
Education, Medical, Graduate | 1 | 1997 | 2420 | 0.000 |
Why?
|
Massachusetts | 1 | 1997 | 8888 | 0.000 |
Why?
|
Genetic Variation | 1 | 1998 | 6611 | 0.000 |
Why?
|
Glucose | 1 | 1995 | 4351 | 0.000 |
Why?
|
Anura | 1 | 1982 | 79 | 0.000 |
Why?
|
Cats | 1 | 1982 | 975 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7612 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10757 | 0.000 |
Why?
|
Neural Pathways | 1 | 1982 | 3113 | 0.000 |
Why?
|
Brain Mapping | 1 | 1982 | 6685 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1982 | 22381 | 0.000 |
Why?
|
Mice | 1 | 1982 | 82024 | 0.000 |
Why?
|
Animals | 1 | 1982 | 169222 | 0.000 |
Why?
|